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Abstract: Saw palmetto supplements are one of the most commonly consumed 
supplements by men with prostate cancer and/or benign prostatic hyperplasia (BPH). Some 
studies have found significant improvements in BPH and lower urinary tract symptoms 
(LUTS) with saw palmetto supplementation, whereas others found no benefits. The 
variation in the efficacy in these trials may be a result of differences in the putative active 
components, fatty acids and phytosterols, of the saw palmetto supplements. To this end, we 
quantified the major fatty acids (laurate, myristate, palmitate, stearate, oleate, linoleate) and 
phytosterols (campesterol, stigmasterol, β-sitosterol) in 20 commercially available saw 
palmetto supplements using GC-FID and GC-MS, respectively. Samples were classified 
into liquids, powders, dried berries, and tinctures. Liquid saw palmetto supplements 
contained significantly higher (p < 0.05) concentrations of total fatty acids (908.5 mg/g), 
individual fatty acids, total phytosterols (2.04 mg/g), and individual phytosterols, than the 
other supplement categories. Powders contained significantly higher (p < 0.05) concentrations 
of total fatty acids than tinctures, which contain negligible amounts of fatty acids (46.3 mg/g) 
and phytosterols (0.10 mg/g). Our findings suggest that liquid saw palmetto supplements 
may be the best choice for individuals who want to take a saw palmetto supplement with 
the highest concentrations of both fatty acids and phytosterols. 
Keywords: saw palmetto; serenoa repens; prostate; benign prostatic hyperplasia; prostate 
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1. Introduction 
Saw palmetto (Serenoa repens) herbal supplements are commonly used by men to combat benign 
prostatic hyperplasia (BPH), a nonmalignant enlargement of the prostate. In addition to BPH, these 
supplements are commonly consumed by men diagnosed with prostate cancer. In 2007, 5.1%  
(~1.7 million people) of Americans 18 years of age or older reported using saw palmetto in the past  
30 days [1]. In 2011, over $18 million in saw palmetto was sold in the United States, ranking third 
among herbal dietary supplements [2]. A systematic literature review of 11 studies identified saw 
palmetto supplements as one of five commonly used complementary or alternative medicine 
modalities by men with prostate cancer; use was 1.9%–24.9% [3]. Another study found that 13.8% of 
unaffected men whose brothers had been diagnosed with prostate cancer had taken saw palmetto at 
some point in their lives [4]. 
Saw palmetto’s putative mechanism of action is inhibition of 5α-reductase, the enzyme that converts 
testosterone into the more potent androgen dihydrotestoterone [5–10]. Studies that have found saw 
palmetto administration or treatment reduced androgen action support this belief [11–15]; however, not 
all studies have found that saw palmetto inhibits 5α-reductase or has anti-androgen action [16–18]. The 
believed bioactive components of saw palmetto are fatty acids and phytosterols. Saw palmetto extracts 
predominantly consist of fatty acids (~90%) and are unique compared with other extracts and 
vegetable and nut oils [19] in that they are a rich source of the saturated, medium-chain fatty acids 
laurate (12:0) and myristate (14:0) [20]. 
Several studies suggest that the fatty acids in saw palmetto extracts are responsible for its ability to 
inhibit 5α-reductase [21–26], but which fatty acid(s) is/are responsible for the inhibition varies. Some 
research suggests that saw palmetto phytosterols (β-sitosterol, campesterol, stigmasterol), inhibit  
5α-reductase, prostate cancer cell/tumor growth, and/or BPH symptoms [27–31]; however, these 
phytosterols are not unique to saw palmetto extracts [32]. Nevertheless, a combination of fatty acids, 
phytosterols, and other bioactive components may be responsible for beneficial effects reported from 
saw palmetto supplements. 
Saw palmetto extract decreased testosterone-induced prostate hyperplasia [15] in rats and prostate 
cancer progression in TRAMP mice [14]. A number of studies have found that saw palmetto 
supplements improve lower urinary tract symptoms (LUTS) in men suffering from BPH. The two 
largest, highest-quality BPH clinical trials [33,34], however, failed to find a benefit of 
supplementation, leading a systematic literature review to conclude that saw palmetto supplementation 
provides no benefit [35]. 
Although methodological issues or distinctions may be responsible for these conflicting findings, it is 
also possible that differences in the nutrient profiles of the saw palmetto supplements used in the studies 
influenced the results. In support of this possibility, different saw palmetto supplements exhibited varied 
effectiveness in inhibiting 5α-reductase activity and prostate cancer cell proliferation [36,37]. In addition, 
Wolsko et al. found that only 6/26 (26%) of published saw palmetto randomized-controlled trials 
reported performing quantitative analysis on the extract used [38]. This is important because the fatty 
acid content of saw palmetto supplements has been found to be −97% to +140% of stated dosages [39], 
and a separate study found that supplements mean free fatty acid percentages ranged from 40.7%  
to 80.7% [40]. 
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Others have also measured fatty acid [15,20,41–43] or phytosterol content [42,44,45] of saw 
palmetto, but despite the reported differences in saw palmetto supplement contents, to the best of our 
knowledge, no one has characterized both the fatty acid and phytosterol contents of commercially 
available supplements or compared different supplement categories. Thus, we set out to characterize 
these saw palmetto supplement components, hypothesizing that we would find large differences in 
their quantities and composition. 
2. Materials and Methods 
2.1. Sample Procurement 
Twenty commercially available saw palmetto supplements were procured from online and local 
sources. Standard reference material (SRM) 3251, a Serenoa repens extract, was purchased from the 
National Institute of Standards and Technology (NIST; Gaithersurg, MD, USA) to ensure the accuracy 
of the fatty acid and phytosterol analysis [20]. Supplements were classified into the following categories 
based on their physical properties: (1) liquids, (2) powders, (3) dried berries, and (4) tinctures (Table 1). 
2.2. Sample Preparation 
Representative samples from each category were prepared as follows. For liquids, 4–5 gel capsules 
were emptied into a microcentrifuge tube and gently vortexed. For powders, 4–5 powder capsules were 
emptied into a weigh boat and the contents were mixed thoroughly with a spatula to break up any 
lumps; tablets were ground to smooth powder using a mortar and pestle. Dried berries were ground 
using a coffee grinder until they reached a coarse powder texture. Tincture bottles were vortexed 
before taking a sample. SRM ampoules were vortexed and the contents were transferred to 
microcentifuge tubes. Samples, and SRM, were extracted and analyzed in duplicate. Care was taken to 
select the duplicates from the same lot number. All materials were from Fisher Scientific (Pittsburgh, 
PA, USA) unless noted. 
2.3. Fatty Acid Extraction and Transesterification 
Fatty acids were prepared for analysis using the one-step extraction-transesterification method [46]. 
Approximately 40 mg of SRM, 40 mg of liquid supplements, 150 mg of powder supplements, 150 mg 
of dried berry powder, or 250 mg of tinctures were placed into 15 mL tubes with Teflon-lined screw 
caps. These amounts were selected because they were estimated to contain ~10–50 mg of total fatty 
acids based on label information. Two milliliters of benzene containing 2 mg of the internal standard 
methyl tridecanoate (Sigma-Aldrich, St. Louis, MO, USA) and 3 mL of freshly prepared methanolic-HCl 
were added. The tubes were capped, vortexed, and incubated at 70 °C for 2 h in a water bath. After 
allowing them to cool to room temperature, 5 mL of 6% potassium carbonate and 2 mL of benzene 
were added, and the tubes were vortexed and centrifuged at 500× g for 5 min. The supernatant was 
carefully transferred to vials for analysis. 
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Table 1. Saw palmetto supplements’ names, manufacturing locations, and other  
label ingredients. 
Saw Palmetto Supplement Other Label Ingredients Lot Number
Liquids  
Doctor’s Best (San Clemente, CA, USA) Gelatin, glycerin, water 9I1215 
GNC Herbal Plus (Pittsburgh, PA, USA) 
Olive oil, gelatin, glycerin, caramel 
color, titanium dioxide 
NI 
Spring Valley Natural Foods (Springfield, MO, USA) Olive oil, gelatin, glycerin, water 36994690904
Now Foods (Bloomingdale, IL, USA) Extra virgin olive oil, gelatin, glycerin 11676001159
Solaray (Park City, UT, USA) Extra virgin olive oil, gelatin, glycerin 132812 
Saw Palmetto Harvesting Company  
(Lengby, MN, USA) 
NI NI 
Jarrow Formulas (Los Angeles, CA, USA) 
Pumpkin seed oil, vitamin E, gelatin,  
glycerin, water 
43044J9 
Powders  
Permixon (Pierre Fabre Medicament,  
Boulogne Cedex, France) 
NI G06167 
Biochem (Country Life, Hauppauge, NY, USA) 
Pygeum extract, magnesium stearate, 
calcium silicate, magnesium silicate, 
silica, cellulose 
09G802C 
Natures’ Way Products, Inc. (Springville, UT, USA) Magnesium stearate, gelatin, glycerin 585612 
Solaray (Park City, UT, USA) Vegetable cellulose capsule 140401 
GNC Saw Palmetto Formula (Pittsburgh, PA, USA) 
Pumpkin seed meal powder, pygeum 
bark powder, lycopene, zinc, 
cellulose, dicalcium phosphate, 
povidone 
5795KJ3613
Dried Berries  
Mountain Rose Herbs  
(Dried Berries, Eugene, OR, USA) 
None 9498 
Mountain Rose Herbs  
(Powdered Berries, Eugene, OR, USA) 
None 9646 
More than alive  
(Powdered Berries, Lobelville, TN, USA) 
None NI 
Tinctures  
Oregon’s Wild Harvest (Sandy, OR, USA) Organic alcohol, water SB12159E01
GAIA Herbs, Inc. (Brevard, NC, USA) Grain alcohol 6212054600 
LA Naturals (Michigan City, IN, USA) 
Grain alcohol 70%–80%,  
deionized water 
7R44ALL 
Teeter Creek Herbs (Ava, MO, USA) 
Grain alcohol 40%–50%,  
distilled water 
NI 
Nature’s Answer (Hauppauge, NY, USA) 
Vegetable glycerin, purified United 
States Pharmacopeia (USP) water 
092469 
NI: no information on the label. 
2.4. Fatty Acid Methyl Esters (FAMEs) Gas Chromatography-Flame Ionization Detector  
(GC-FID) Analysis 
Sample extracts were analyzed for fatty acid methyl esters using a Hewlett-Packard model 5890 GC 
(Hewlett-Packard, Palo Alto, CA, USA) with a SP-2560 capillary column (100 m × 0.25 mm × df  
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0.2 μm, Supelco, Inc., Bellefonte, PA, USA). Injection port and detector temperatures were maintained 
at 250 °C. Helium was used as the carrier gas at a flow rate of 1 mL/min. One microliter of sample was 
injected at a split ratio of 100:1. A temperature gradient was used with an initial oven temperature of 
140 °C that increased to 200 °C at 2 °C/min, then to 245 °C at 4 °C/min, and the sample held at this 
temperature for 17 min. The total run time was 66 min. Fatty acid methyl esters (FAMEs) were 
identified by their retention times using the FAME standard mix (Supelco, Bellefonte, PA, USA) and 
quantified using Agilent ChemStation software [47]. Thirty-seven fatty acids were analyzed and 
quantified and contributed to the total fatty acid results reported, but only the six major fatty acids, 
laurate (C12:0), myristate (C14:0), palmitate (C16:0), stearate (C18:0), oleate (C18:1), and linoleate 
(C18:2), are reported individually. The mean percent coefficient of variance between duplicates for 
total fatty acids was 0.8%. 
2.5. Phytosterol Extraction 
Phytosterols were extracted using a method described previously with modifications [48]. 
Approximately 100 mg of SRM, liquid, powder, and dried berry supplements and 1000 mg of tincture 
supplements were weighed into separate 250 mL Erlenmeyer flasks. Forty milliliters of 0.3 M 
potassium hydroxide in methanol and 10 µL (1 mg/mL chloroform) of cholestanol (Steraloids, Inc., 
Newport, RI, USA) were added to each flask. The extracts were distilled at 80 °C using a condenser 
for 1 h with continuous stirring. After cooling the flasks to room temperature, 40 mL of  
double-distilled water was added. Twenty milliliters of hexane was then added, and the contents were 
transferred to a separatory funnel. The separatory funnel was carefully inverted, gently rotated, then 
allowed to stand for 5–10 min. The bottom white turbid aqueous layer was discarded retaining the 
clear upper hexane layer. The contents of the separatory funnel were then extracted by adding 20 mL 
of hexane twice. The clear hexane layers were collected and filtered through a glass funnel containing 
glass wool and sodium sulfate. Filtered hexane extracts were concentrated using a Brinkmann Buchi 
Rotavapor R110 (Buchi, Switzerland) at 50 °C, transferred to test tubes, then evaporated to dryness 
under nitrogen. The dried contents were redissolved in 1 mL of chloroform and stored at −80 °C  
for derivatization. 
2.6. Phytosterol Derivatization 
Phytosterols were derivitaized and analyzed by gas chromatography-mass spectrometry as 
described previously with modifications [49]. Two hundred microliters of extracted sample was used 
for derivatization. A smaller volume was used for samples that contained high levels of phytosterols. 
Samples were placed in 1.5 mL screw-cap GC vials (Agilent, Santa Clara, CA, USA), dried 
completely under nitrogen, and redissolved in 70 µL pyridine (99.5% extra dry with AcroSeal, Acros 
Organics, Geel, Belgium) for derivatization. The samples in pyridine were derivatized by adding  
30 µL of N-trimethylsilyl-N-methyltrifluoroacetamide with 1% trimethylchlorosilane (MSTA + 1% 
TMCS Thermo Scientific, Bellefonte, PA, USA) and incubated at 50 °C for 60 min on a hot plate. 
Derivatized samples were completely dried down under nitrogen, redissolved in 100 µL of chloroform, 
and analyzed within 24 h of derivatization. 
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2.7. Phytosterol Gas Chromatography-Mass Spectrometry (GC-MS) 
GC-MS was performed on an Agilent 6890N GC coupled to an Agilent 5975N quadruple mass 
selective detector. The GC was fitted with a DB-5MS capillary column (60 m × 0.25 mm × df  
0.25 µm, Agilent Technologies, Santa Clara, CA, USA) with a 5% phenyl methyl siloxane stationary 
phase. Helium was used as the carrier gas at a column flow rate of 1 mL/min. The front inlet was operating 
at a pressure of 22.33 psi and 280 °C. An Agilent 7683 autosampler was used to inject 1 µL of the sample 
in the splitless mode. The GC temperature program was: initial temperature of 80 °C, increased 25 °C/min 
to 300 °C, then increased 3 °C/min to a final temperature of 325 °C, where it was held for 7 min. The total 
run time was 24.5 min. The mass spectrometer was operated in the electron impact (EI) mode at 70 eV 
ionization energy. The MS quad temperature was at 150 °C, and the MS source temperature was at 230 °C. 
The data were processed with Agilent Chemstation. The three major phytosterols campesterol, 
stigmasterol, β-sitosterol, were quantified and summed to calculate total phytosterol content. The mean 
percent coefficient of variance between replicates for total phytosterol was 10.8%. 
2.8. Statistical Analysis 
Data were analyzed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA), with p < 0.05 considered 
significant. Natural logs were used to transform data that did not meet the assumptions of normality 
and/or homogeneity of variance. Differences in individual fatty acid and phytosterol quantities and 
percentages, total fatty acid and phytosterol quantities, and percentages among the four supplement 
categories were analyzed using one-way ANOVA with Tukey’s test. The variation between duplicates 
was assessed by dividing the standard deviation with duplicate mean and multiplying with 100 to 
calculate the mean percent coefficient of variation. 
3. Results 
3.1. Fatty Acid Quantities and Percentages between Supplement Categories 
Fatty acid quantities and percentages of the SRM, liquid, powder, dried berry, and tincture saw 
palmetto supplements are shown in Tables 2 and 3. Nature’s Answer was not included in the tincture 
means and was excluded from statistical analysis due to its negligible fatty acid content (0.1 mg/g). 
Oleate and laurate were the predominant fatty acids across the different supplement categories. Liquid 
supplements contained significantly higher quantities of total (908.5 mg/g) and individual fatty acids 
than powder, dried berry, and tincture supplements. Liquid supplements contained significantly higher 
percentages of oleate and total fatty acids and significantly lower percentages of laurate and myristate 
than the other supplement categories. The total fatty acid content of powder supplements (179.6 mg/g) 
was similar to dried berry (126.4 mg/g) but significantly higher than tincture supplements (46.3 mg/g). 
Powder supplements contained significantly higher quantities of palmitate and stearate than dried 
berries and tinctures and significantly higher quantities of linoleate and total fatty acids than dried 
berries. Powder supplements contained significantly higher palmitate and stearate percentages than the 
other supplement categories, and tinctures contained significantly higher percentages of laurate than 
liquid and powder supplements. 
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Table 2. Fatty acid quantities (mg/g) and composition (% of total fatty acids) in SRM, liquid, and powder saw palmetto supplements. 
 
Supplement 
Laurate  
(C12:0) 
Myristate 
(C14:0) 
Palmitate 
(C16:0) 
Stearate 
(C18:0) 
Oleate  
(C18:1) 
Linoleate 
(C18:2) 
Total Fatty 
Acid 
 mg/g % mg/g % mg/g % mg/g % mg/g % mg/g % mg/g % * 
Liquid Extracts (n = 7) 
Doctor’s Best 276.6 29.4 105.4 11.2 86.9 9.2 17.5 1.9 313.9 33.4 43.6 4.6 941.3 94.1 
GNC Herbal Plus 82.9 8.9 33.8 3.6 94.0 10.1 25.4 2.7 582.3 62.4 59.1 6.3 933.8 93.4 
Spring Valley Natural Foods 170.3 18.5 67.6 7.3 85.8 9.3 24.1 2.6 448.5 48.6 53.9 5.8 923.4 92.3 
Now Foods 141.6 15.5 51.6 5.7 107.0 11.7 21.1 2.3 438.1 47.9 81.0 8.9 914.7 91.5 
Solaray 141.9 15.6 57.1 6.3 90.9 10.0 21.2 2.3 476.0 52.1 55.6 6.1 913.0 91.3 
Saw Palmetto Harvesting Company 254.9 28.3 98.5 11.0 84.4 9.4 16.2 1.8 312.5 34.7 34.1 3.8 900.0 90.0 
Jarrow Formulas 127.2 15.3 47.5 5.7 93.1 11.2 32.5 3.9 230.2 27.6 248.2 29.8 833.4 83.3 
Mean 170.8 a 18.8 a 65.9 a 7.2 a 91.7 a 10.1 a 22.6 a 2.5 a 400.2 a 43.8 a 82.2 a 9.3 a 908.5 a 90.9 a 
SEM 18.0 1.9 6.9 0.7 2.0 0.2 1.4 0.2 30.9 3.2 19.2 2.4 9.6 1.0 
Powders (n = 5) 
Permixon 96.7 29.5 38.5 11.8 30.5 9.3 5.6 1.7 111.7 34.1 11.5 3.5 327.3 32.7 
Biochem 40.7 17.1 16.2 6.8 58.2 24.4 47.0 19.7 36.4 15.3 19.1 8.0 238.3 23.8 
Natures’ Way 38.0 26.5 14.3 10.0 18.2 12.7 14.4 10.0 40.1 27.9 6.5 4.5 143.6 14.4 
Solaray 40.5 33.7 14.8 12.3 11.9 9.9 2.5 2.1 34.2 28.5 6.1 5.1 120.1 12.0 
GNC Saw Palmetto Formula 14.6 21.3 5.6 8.2 15.2 22.1 9.6 13.9 14.6 21.2 4.6 6.7 68.6 6.9 
Mean 46.1 b 25.6 b 17.9 b 9.8 b 26.8 b 15.7 b 15.8 b 9.5 b 47.4 b 25.4 b 9.6 b 5.6 a 179.6 b 18.0 b 
SEM 9.0 2.0 3.7 0.7 5.7 2.1 5.4 2.3 11.1 2.2 1.8 0.5 30.7 3.1 
Standard Reference Material 
SRM 3251 259.9 26.3 10.6 10.6 86.6 8.5 16.9 1.7 331.1 34.6 50.2 6.0 983.6 98.4 
* % of dry mass (weight/weight), different letters indicate significant differences (p < 0.05) between the four supplement categories in Tables 2 and 3. Samples and SRM from the same lot, 
were extracted and analyzed in duplicate. 
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Table 3. Fatty acid quantities (mg/g) and composition (% of total fatty acids) in dried berry and tincture saw palmetto supplements. 
Supplement 
Laurate  
(C12:0) 
Myristate 
(C14:0) 
Palmitate 
(C16:0) 
Stearate  
(C18:0) 
Oleate  
(C18:1) 
Linoleate 
(C18:2) 
Total Fatty  
Acid 
 mg/g % mg/g % mg/g % mg/g % mg/g % mg/g % mg/g % * 
Dried berries (n =3) 
Mountain Rose Herbs (dried berries) 41.7 31.1 15.1 11.3 12.4 9.3 2.6 1.9 41.2 30.8 6.6 4.9 134.0 13.4 
Mountain Rose Herbs  
(powdered berries) 
37.1 28.6 15.6 12.0 12.6 9.7 2.1 1.7 43.9 33.9 4.8 3.7 129.7 13.0 
More than Alive (powdered berries) 37.5 32.5 14.1 12.2 11.5 9.9 2.2 1.9 34.6 30.0 5.6 4.9 115.7 11.6 
Mean 38.8 b 30.7 b,c 14.9 b 11.8 b 12.2 c 9.6 a 2.3 c 1.8 a 39.9 b 31.5 b 5.7 b 4.5 a 126.4 b,c 12.6 b,c 
SEM 0.9 0.7 0.3 0.2 0.2 0.1 0.1 0.1 1.7 0.8 0.3 0.3 3.5 0.3 
Tinctures (n = 5) 
Oregon’s Wild Harvest 28.4 29.2 10.6 10.9 8.7 9.0 1.7 1.8 32.0 32.9 4.5 4.6 97.3 9.7 
GAIA Herbs 22.8 35.2 9.3 14.3 5.5 8.4 0.6 1.0 20.1 31.0 1.2 1.9 64.8 6.5 
LA Naturals  5.1 40.2 1.7 13.4 1.1 8.6 0.2 1.4 3.0 23.1 0.7 5.6 12.8 1.3 
Teeter Creek 3.7 36.5 1.2 11.6 0.7 7.4 0.1 1.3 2.4 23.6 0.3 2.7 10.1 1.0 
Nature’s Answer ** 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.1 0.0 
Mean 15.0 b 35.3 c 5.7 b 12.5 b 4.0 c 8.3 a 0.7 c 1.4 a 14.3 b 27.6 b 1.7 c 3.7 a 46.3 c 4.6 c 
SEM 4.1 1.5 1.6 0.5 1.2 0.2 0.2 0.1 4.7 1.6 0.6 0.6 13.9 1.4 
* % of dry mass (weight/weight), ** Nature’s Answer was excluded from statistical analysis due to its negligible fatty acid content compared with other products. Different letters indicate 
significant differences (p < 0.05) between the four supplement categories in Tables 2 and 3. Samples, and SRM from the same lot, were extracted and analyzed in duplicate. 
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3.2. Fatty Acid Quantities and Percentages within Supplement Categories 
Within supplement categories, fatty acid quantities and percentages across the three dried berry 
supplements were fairly consistent (Tables 2 and 3). Tinctures, on the other hand, varied widely, with 
total fatty acids ranging from 0.1 to 97.3 mg/g. There was less variability in total fatty acids in liquids 
(710.3–941.3 mg/g) and powder (68.6–327.3 mg/g) supplements; however, there were some notable 
trends. Among liquid supplements, Doctor’s Best and Saw Palmetto Harvesting Company contained 
higher laurate and myristate and lower oleate quantities. Jarrow Formulas contained much higher 
quantities of linoleate than the other liquid supplements. Among powder supplements, Biochem 
contained lower quantities of laurate and myristate levels but higher quantities of stearate and oleate. 
3.3. Phytosterol Quantities and Percentages between Supplement Categories 
Phytosterol quantities and percentages in SRM, liquid, powder, dried berry, and tincture saw 
palmetto supplements are shown in Tables 4 and 5. Jarrow formulas (8.33 mg/g) and Biochem  
(22.80 mg/g) were not included in category means and were excluded from statistical analysis due to 
very high phytosterol content compared with the other supplements. β-Sitosterol was the predominant 
phytosterol (47.32%–79.48%) in all saw palmetto supplements. Liquid supplements contained 
significantly higher total (2.04 mg/g) and individual phytosterol quantities than powders, dried berry, 
and tincture supplements. Liquid supplements also contained a significantly higher percentage of  
β-sitosterol than the other supplement categories and a lower percentage of campesterol compared with 
powders and dried berry supplements. The total phytosterol content of powders (0.42 mg/g) and dried 
berries were similar, but powder supplements (0.33 mg/g) contained significantly higher phytosterol 
quantities than tincture supplements (0.10 mg/g). Dried berries also contained significantly higher 
stigmasterol quantities than tincture supplements. Dried berry supplements contained a significantly 
higher and lower percentage, respectively, of campesterol and β-sitosterol than the other supplement 
categories. Dried berry and tincture supplements also contained significantly higher percentages of 
stigmasterol than liquid and powder supplements. 
3.4. Phytosterol Quantities and Percentages within Supplement Categories 
Liquid and powder supplements had similar quantities of individual and total phytosterols, with the 
exception of Jarrow Formulas and Biochem, which contained much higher phytosterol quantities 
(Tables 4 and 5). Dried berry supplements had similar quantities and percentages of individual and 
total phytosterols. All tincture supplements contained low phytosterols quantities. 
3.5. Difference between Stated and Measured Total Fatty Acid Content 
Stated total fatty acid content from supplement labels was only available for liquid supplements. 
These stated quantities are compared to measured content in Table 6. Measured total fatty acid content 
in five out of six liquid supplements was greater than or equal to the quantities stated on their labels. It 
is worth noting that one supplement whose measured content (833 mg/g) was below its stated amount, 
Jarrow Formulas, was only 7% lower than its stated content (850–950 mg/g). 
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Table 4. Phytosterol quantities (mg/g) and composition (% of total phytosterols) in SRM, liquid and powder saw palmetto supplements. 
Supplement Campesterol Stigmasterol β-sitosterol Total Phytosterols 
 mg/g % mg/g % mg/g % mg/g % * 
Liquids 
Jarrow Formulas ** 8.33 29.09 4.01 14.03 16.29 56.88 28.63 2.86 
Doctor’s Best 0.54 19.21 0.24 8.53 2.04 72.26 2.83 0.28 
Now Foods 0.29 12.56 0.13 5.66 1.92 81.78 2.35 0.23 
Saw Palmetto Harvesting Company 0.34 21.05 0.16 10.09 1.12 68.86 1.62 0.16 
Solaray 0.23 11.10 0.11 5.19 1.73 83.71 2.07 0.21 
Spring Valley Natural Foods 0.15 7.20 0.11 5.52 1.80 87.28 2.06 0.21 
GNC Herbal Plus 0.15 11.61 0.07 5.40 1.08 82.99 1.31 0.13 
Mean 0.28 a 13.79 a 0.14 a 6.73 a 1.62 a 79.48 a 2.04 a 0.20 a 
SEM 0.04 1.45 0.02 0.57 0.12 1.99 0.15 0.02 
Powders 
Biochem ** 22.80 30.30 19.75 26.55 32.55 43.15 75.11 7.51 
Permixon 0.18 21.06 0.06 7.68 0.60 71.27 0.84 0.08 
Nature’s Way 0.10 24.65 0.04 11.11 0.25 64.24 0.39 0.04 
Solaray 0.07 23.89 0.03 9.30 0.20 66.80 0.30 0.03 
GNC Saw Palmetto Formula 0.03 19.83 0.01 9.19 0.10 70.98 0.15 0.01 
Mean 0.09 b 22.36 b 0.04 b,c 9.32 a 0.29 b 68.32 b 0.42 b 0.04 b 
SEM 0.02 0.90 0.01 0.53 0.07 1.33 0.10 0.01 
Standard Reference Material 
SRM 3251 0.41 19.69 0.18 8.57 1.48 71.74 2.06 0.21 
* % dry mass (weight/weight), ** Jarrow Formulas and Biochem were excluded from statistical analysis due to their very high phytosterol content compared with other supplements. Different 
letters indicate significant differences (p < 0.05) between the four supplement categories in Tables 4 and 5. Samples, and SRM from the same lot, were extracted and analyzed in duplicate. 
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Table 5. Phytosterol quantities (mg/g) and composition (% of total phytosterols) in dried berry and tincture saw palmetto supplements. 
Supplement Campesterol Stigmasterol β-sitosterol Total Sterols 
 mg/g % mg/g % mg/g % mg/g % * 
Dried berries 
Mountain Rose Herbs (dried berries) 0.16 41.45 0.09 21.91 0.13 36.64 0.38 0.04 
Mountain Rose Herbs (powdered berries) 0.09 27.93 0.06 17.41 0.17 54.66 0.32 0.03 
More Than Alive (powdered berries) 0.08 27.28 0.07 22.06 0.15 50.66 0.30 0.03 
Mean 0.11 b 32.22 c 0.07 b 20.46 b 0.15 b 47.32 c 0.33 b,c 0.03 b 
SEM 0.02 3.30 0.01 2.86 0.01 5.16 0.03 0.00 
Tinctures 
Oregon’s Wild Harvest 0.04 16.40 0.02 9.16 0.18 74.45 0.24 0.02 
GAIA Herbs 0.03 17.95 0.02 11.65 0.11 70.40 0.16 0.02 
LA Naturals Saw Palmetto drops 0.01 16.73 0.01 13.72 0.04 69.55 0.06 0.01 
Nature’s Answer  0.00 21.12 0.00 25.23 0.01 53.65 0.02 0.00 
Teeter Creek 0.01 22.27 0.00 14.71 0.02 63.02 0.02 0.00 
Mean 0.02 b 18.89 a,b 0.01 c 14.89 b 0.07 b 66.21 b 0.10 c 0.01 b 
SEM 0.00 0.83 0.00 1.86 0.02 2.47 0.03 0.00 
* % of dry mass (weight/weight), different letters indicate significant differences (p < 0.05) between the four supplement categories in Tables 4 and 5. Samples, and SRM from the same lot, 
were extracted and analyzed in duplicate. 
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Table 6. Stated, measured, and percentage difference in total fatty acid content in liquid 
saw palmetto supplements. 
Product Name 
Stated Content 
(mg/g) 
Measured Content 
(mg/g) 
% Difference 
Doctor’s Best 900 941 +5 
GNC Herbal Plus 850 934 +10 
Spring Valley Natural Foods 850–950 923 +3 
Now Foods 850–950 915 +2 
Solaray 850 913 +7 
Jarrow Formulas 850–950 833 −7 
4. Discussion 
We found great variability in total and individual fatty acid and phytosterol quantities and 
percentages in 20 commercial saw palmetto supplements. There was also a great deal of variability in 
the total and individual fatty acid and phytosterol quantities and percentages between the four different 
saw palmetto supplement categories. We believe we are the first to collect and analyze samples from 
these different supplement categories. Overall, we found that liquid supplements contained the highest 
fatty acid and phytosterol quantities, followed by powder, dried berry, and tincture supplements. 
Fatty acid and phytosterol contents have been reported previously for SRM 3251 [20]. Because total 
fatty acid quantities were not reported, we multiplied the reported free fatty acid composition by the 
triglyceride to free fatty acid ratio. Our measured total fatty acid and total phytosterol contents  
(908.5 mg/g, 2.0 mg/g) are comparable with the calculated SRM 3251 values (983.6 mg/g, 2.4 mg/g) [20]. 
These results support that our extraction and analysis procedures were accurate in measuring these 
components. The total fatty acid percentages of liquid samples (83.3%–94.1%) are consistent with the 
values reported for hexane (98.7%–99.7%) [41], supercritical CO2 (96.1%–97.4%) [42], CO2 (92.2%) [43], 
ethanol (88.7%) [43] and lipid (92.5%) [15] saw palmetto extracts. The total fatty acid percentages are 
also consistent with the sum of the free fatty acids, esters, and glycerides (87.0%–95.3%) in  
14 European saw palmetto extracts [40]. However, the total fatty acid percentages are higher than 
those reported for a saw palmetto ethanol extract (68.7%) [43]. 
Dried berry supplements contained 11.6%–13.4% fatty acids, which is similar to the levels reported 
in SRM 3250 (~15.8%), a saw palmetto berry, when calculated as described above [20]. Permixon, one 
of the powder supplements, has been analyzed previously and reported to contain 91.4% free fatty 
acids, esters, and glycerides [40]. This was far higher than the 32.7% fatty acid content that we 
measured. Our method may not extract fatty acids efficiently from powder samples and could be 
underestimating the fatty acid content. To the best of our knowledge, we are the first to measure 
tincture saw palmetto supplements. The levels of the major phytosterols (campesterol, stigamasterol, 
and β-sitosterol) in the saw palmetto supplements is consistent with quantities found in a variety of 
previously analyzed saw palmetto supplements [44] and is similar to the β-sitosterol content in a 
supercritical CO2 saw palmetto extract [42]. 
Ingredients added to saw palmetto supplements (Table 1) help explain the differences we found in 
fatty acid and phytosterol quantities and percentages. Most liquid, and a few powder, supplements 
contain added ingredients. For instance, among liquid supplements, only Doctor’s Best and Saw 
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Palmetto Harvesting Company had no or a limited number of extra ingredients added to them. This 
probably explains why they have much higher laurate and myristate quantities. Jarrow Formulas, on 
the other hand, has a pumpkin seed oil base that is enriched in phytosterols, which explains its high 
linoleate and phytosterol quantities. The remaining four liquid supplements contained either olive oil 
or extra virgin olive oil (GNC Herbal Plus, Spring Valley Natural Foods, Now Foods, Solaray) which 
explains their higher oleate percentages compared to other liquid supplements. The powder 
supplements Nature’s Way and Biochem contain magnesium stearate, which explains their high 
quantities of stearate. Biochem also contains pygeum root extract, which is probably the reason why 
the supplement contains very high quantities of phytosterols [50]. 
Industrial preparative extraction methods may also help explain the differences in fatty acid and 
phytosterol quantities in the supplements. Saw palmetto supplements are usually extracted using 
solvents like hexane, ethyl alcohol, or supercritical CO2. All the tinctures were alcohol-extracted, but 
among liquid and powder supplements, only Doctor’s Best and Jarrow Formulas, which were extracted 
using supercritical CO2, stated how they were extracted. Thus, the unknown methods used to produce 
the supplements prevent us from understanding how extraction affects supplement fatty acid and 
phytosterol content. Other factors that might also contribute to the observed variation are batch 
differences and plant growing conditions. 
We found that 83% of the liquid supplements contained greater than or equal to their stated fatty 
acid content. This is higher than the 33% of the measured saw palmetto supplements analyzed in a 
previous study [39]. Supplement companies that state their fatty acid content may be employing better 
manufacturing procedures and analyzing their products to ensure they contain the stated values. 
5. Implications 
Our findings suggest that liquid saw palmetto supplements are the best choice for individuals who 
want to take a saw palmetto supplement that has the highest concentration of both fatty acids and 
phytosterols. However, further research is needed to determine whether these supplements are indeed 
more efficacious. 
6. Conclusions 
We believe we are the first to characterize both fatty acid and phytosterol content of commercial 
saw palmetto supplements. We plan to determine the anti-androgen action of saw palmetto 
supplements with different nutrient profiles hoping that the understanding gained will explain the 
varied response to saw palmetto supplements seen in previous studies. 
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